We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Clean Power Hydrogen Plc | CPH2 | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.05 | 0.69% | 7.25 | 10:04:45 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 7.20 | 7.15 | 7.25 | 7.25 | 7.20 |
| Industry Sector |
|---|
| ALTERNATIVE ENERGY |
| Top Posts |
|---|
Posted at 07/11/2024 15:13 by paleje Equity Developnment have a long (18 page) research note out on the hydrogen sector, CPH2 are in there right at the very end. |
Posted at 05/11/2024 10:13 by smackeraim Feature on #CPH2 in todays @DailyMailUKhttps:// |
Posted at 04/11/2024 10:55 by smackeraim H2 View understands Hidrigin has 100m ($108m) funding terms in place to build out its renewable energy portfolio with the green hydrogen pilot, with the ultimate goal of developing 500m ($544m) of its own projects and CPH2 electrolysers. |
Posted at 04/11/2024 09:00 by rental Cavendish snippetWe believe the licence fee is a multi-million Euro sum and will be activated following the delivery of the first MFE220 and paid in staged payments over a period of two years. Once in production, CPH2 will receive revenues from the sale of components and a technology fee per unit manufactured which we believe will be in the low hundreds of thousands of Euros per MW, making the 2GW licence worth potentially hundreds of millions to CPH2. |
Posted at 04/10/2024 08:17 by andrew000 Sadly nothing for cph2... |
Posted at 27/9/2024 17:38 by pj84 Cavendish have reduced their price target from 81p to 66p and expect a fundraise in early 2025 which should get CPH2 through to breakeven in 2027You can read the note by clicking on the link on CPH2's website Which will take you to the report on Cavendish's website, if you haven't previously registered, you can register for free to access the report. |
Posted at 26/9/2024 07:23 by lord orphan It's a potential 4-bagger just to get back to the IPO price. It's a great sign that Northern Ireland Water has stuck with them. Labour seems keen on supporting the hydrogen sector and CPH2 is in Miliband's Doncaster constituency. |
Posted at 30/8/2024 22:28 by rental From there RNS last yearIt’s now August, so really we need an RNS either confirming completion or telling us a new timescale as it’s very clear we are not Early 2024 it’s September tomorrow. This is their legal obligation. “”It is NI Water's assessment that whilst challenges remain in proving the logic controls and shutdown procedures, CPH2 will address these in time to ensure delivery to Belfast in early 2024." |
Posted at 25/7/2024 08:51 by supernumerary This is what they said after Level 1:'The Company is now proceeding with Level 2 of the FAT protocol, which verifies a broad range of checks and calibrations for the MFE110. Once the functional checks of the MFE110 are completed, CPH2 will begin Level 3 FAT, the final testing procedure once the MFE110 electrolyser has been fully commissioned and is producing hydrogen and oxygen.' I assume they will tell us when Level 2 is complete (as they did with L1), and will then start L3. I don't see all that happening this month. But then, I'm a glass half-empty sort of person :¬( |
Posted at 06/6/2024 20:31 by rental Taken from Clean Power Hydrogens LinkedIn post 3 weeks ago,——— Liberum has published its latest note on #CPH2 reiterating a BUY rating with a target price of 68p. Sam Wahab, Research Analyst at Liberum commented: “Licence deals with Fabrum and KCA Deutag continue to underpin the company’s long-term investment case in our view, while near-term, successfully delivering a commercial unit to NI Water will represent key validation of CPH2’s differentiated technology.” #hydrogenproduction #hydrogeneconomy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
